Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-24 4:13 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 2,717,171 5.75% | 450,602 (+19.88%) | View |
| 2023-02-14 4:21 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group LLC | 4,899,772 9.9% | 1,941,488 (+65.63%) | View |
| 2023-02-14 4:04 pm Sale | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 184,544 0.4% | -2,366,213 (-92.77%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | BAKER BROS. ADVISORS LP | 4,801,954 9.99% | 2,347,872 (+95.67%) | View |
| 2023-02-14 12:38 pm Sale | 13G | Nurix Therapeutics, Inc. NRIX | PRICE T ROWE ASSOCIATES INC | 3,253,736 6.9% | -1,617,348 (-33.20%) | View |
| 2023-02-14 08:50 am Sale | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 2,266,569 4.81% | -169,595 (-6.96%) | View |
| 2023-02-10 10:54 am Purchase | 13G | Nurix Therapeutics, Inc. NRIX | STATE STREET CORP STT | 2,507,987 5.32% | 2,507,987 (New Position) | View |
| 2023-02-08 1:07 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | WASATCH ADVISORS INC | 2,538,632 5.4% | 2,538,632 (New Position) | View |
| 2023-01-25 10:36 am Purchase | 13G | Nurix Therapeutics, Inc. NRIX | BlackRock Inc. BLK | 4,142,528 8.8% | 1,594,667 (+62.59%) | View |
| 2022-06-10 4:02 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 2,436,164 5.19% | 2,436,164 (New Position) | View |
| 2022-02-14 5:07 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group LLC | 2,958,284 6.6% | 112,159 (+3.94%) | View |
| 2022-02-14 4:57 pm Sale | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 2,550,757 5.7% | -2,871,792 (-52.96%) | View |
| 2022-02-14 4:15 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | BAKER BROS. ADVISORS LP | 2,454,082 5.5% | 2,454,082 (New Position) | View |
| 2022-02-14 2:35 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | PRICE T ROWE ASSOCIATES INC | 4,871,084 10.9% | 244,189 (+5.28%) | View |
| 2022-02-11 4:34 pm Sale | 13G | Nurix Therapeutics, Inc. NRIX | COLUMN GROUP L P | 654,245 1.5% | -6,101,636 (-90.32%) | View |
| 2022-02-11 3:11 pm Sale | 13G | Nurix Therapeutics, Inc. NRIX | Foresite Capital Fund IV L.P. | 1,205,798 2.7% | -2,045,051 (-62.91%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | BlackRock Inc. BLK | 2,547,861 5.7% | 2,547,861 (New Position) | View |
| 2022-02-04 09:21 am Sale | 13G | Nurix Therapeutics, Inc. NRIX | WELLINGTON MANAGEMENT GROUP LLP | 1,162,316 2.61% | -1,285,268 (-52.51%) | View |
| 2021-08-10 1:41 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | PRICE T ROWE ASSOCIATES INC | 4,626,895 10.4% | 4,626,895 (New Position) | View |
| 2021-02-16 4:15 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 5,422,549 14% | 5,422,549 (New Position) | View |